Description

SAE Media Group presents the 5th Annual Wearable Injectors and Connected Devices Conference on October 14th-15th, 2024, in London, UK.

Explore on-body device design, connectivity, and digital health applications with industry insights from big pharma. Discover key developments in wearable injectors, including demand for on-body devices and digitalized health for at-home self-administration of time-dependent, high-volume drugs.

Engage with regulatory updates, user-experience considerations, and patient-centric device development. Network over two days, with 75% of speakers from big pharma, and gain insights into wearable injector technologies, regulatory processes, and connectivity implementation.

Join pharma, biotech, and device developers to discuss trends, challenges, and strategies. Learn about regulatory approval processes and usability for at-home injectors. Connect with industry leaders and stakeholders to explore the future of digital health and on-body drug delivery systems.

URLs:
Tickets: https://go.evvnt.com/2446046-0?pid=10007
Brochure: https://go.evvnt.com/2446046-2?pid=10007

 

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Development

Price:
Wearable Injectors and Connected Devices UK (EARLY BIRD DISCOUNT UNTIL 06/09/24: GBP 2099.00

Speakers: ANDREW CHAPMAN – Senior Director, AstraZeneca, BERNA KOSEKAYA – Regulatory Professional, Novo Nordisk, CHARLES POTTER – Technical Project Leader, Chiesi Ltd, CHRISTIAN PROFF – Senior Verification Engineer, Roche, CINZIA ROTELLA – Project Leader, Sanofi, ESTHER GRANDAL – DELGADO Senior Regulatory Affairs Devices, Novo Nordisk, FAUSTO ARTICO – Global R and D Data and AI Strategy Leader, Argenx, JULIAN DIXON – Former Senior Director, Human Factors, AstraZeneca, MARION BRIGGS – Circularity Solutions, Johnson and Johnson, SCOTT EWAN – MediPhorum – Program Manager, Biophorum, SOREN SKOV – Senior Human Factors Engineer, Roche